Eton Pharmaceuticals stock has Q3 results date
Published on 11/02/2026 at 00:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Eton investors should watch
- Eton Pharmaceuticals will release third-quarter 2026 results on November 5.
- Management plans a conference call and webcast at 4:30 p.m. ET, with live and emailed investor questions.
- The company is expanding a rare-disease portfolio that includes twelve commercial products and five late-stage candidates.
Eton Pharmaceuticals will report its third-quarter 2026 financial results on Thursday, November 5, the company said in a news release dated October 29. The announcement sets the next scheduled update for investors and gives management an opportunity to address operating progress and the outlook for the remainder of the year. The company announcement said the call and webcast will begin at 4:30 p.m. ET.
Results date sets next catalyst
Investors will be able to submit questions during the call and by email. The webcast will be available through Eton's investor relations website, while an archived version is expected about two hours after the event and will remain available for 30 days.
The release does not provide the quarter's financial figures or new guidance. The results and management commentary will therefore be the next substantive test of demand for Eton's commercial portfolio, product launches and development programs.
Rare disease portfolio remains central
Eton describes itself as a pharmaceutical company focused on developing and commercializing treatments for rare diseases. Its commercial portfolio includes twelve products, among them INCRELEX, ALKINDI SPRINKLE, HEMANGEOL, IMPAVIDO and LIBERVANT.
The company also lists five late-stage candidates: ASN-001, AMGLIDIA, ET-700, ET-800 and ZENEO hydrocortisone autoinjector. That pipeline gives the November update importance beyond the quarterly income statement, particularly for investors tracking future product launches and regulatory milestones.
The S&P 500 provides the broad US market context for this Nasdaq-listed company; investors can follow the S&P 500 market environment alongside the company-specific event.
Eton Pharmaceuticals at a glance
- Company: Eton Pharmaceuticals, Inc.
- Ticker: ETON
- Exchange: Nasdaq
- Announcement: October 29, 2026
- Next results: November 5, 2026 at 4:30 p.m. ET
